Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...

In April, 2014, Sun Pharma had announced it would acquire Ranbaxy in an all-stock transaction worth USD 4 billion that includes $800 millio...

Sun Pharma said it had "no access to non-public information of Ranbaxy" when its unit Silverstreet bought shares in Ranbaxy.

Shares of Ranbaxy, which is majority-owned by Japan’s Daiichi-Sankyo, saw an unusual increase in price and turnover during six trading days...

An investor who is really confident that the deal will go through can buy Ranbaxy shares and pocket the difference when the merger is compl...

The deal values Ranbaxy shares at Rs 457 apiece, representing an 18 per cent premium to their 30-day volume-weighted average share price.

Shares of Ranbaxy Laboratories today gained nearly 6 per cent after the company's fourth quarter net loss narrowed to Rs 158.94 crore.

Jagdish Malkani, Member NSE & BSE, shares his views on the current situation of Ranbaxy.

Following the news, shares of the company opened the day on a weak note and further tanked 9.3 per cent to Rs 391 on the BSE.

Shares of Ranbaxy today slumped over three per cent on the bourses after the company said it has recalled its cholesterol-lowering drug Ato...

Ranbaxy is expected to report a 33 per cent jump in its net sales for the quarter ended September 30 to Rs 2698 crore.

Ranbaxy laboratories has received an approval for an anti acne drug Absorica developed by US firm Cipher, the company said in a release to ...

Pharma analysts are apprehensive that the investigations against Ranbaxy might impact its product flow to US and its out-of-court settlemen...

The Ranbaxy Laboratories scrip rose 6.53% on Tuesday to a 52-week high amid speculation of a possible stake sale by the promoters or a sale...

The Ranbaxy share price dropped 5% on Thursday in the backdrop of US federal officials conducting a search on the premises of the company’s...